TrialJournal of hematology & oncology2020

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.

Houli Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.